Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
171M
-
Shares change
-
-4.51M
-
Total reported value, excl. options
-
$155M
-
Value change
-
-$4.67M
-
Put/Call ratio
-
0.68
-
Number of buys
-
42
-
Number of sells
-
-39
-
Price
-
$0.90
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q4 2024
127 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q4 2024.
Gossamer Bio, Inc. - Common Stock (GOSS) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 171M shares
of 227M outstanding shares and own 75.36% of the company stock.
Largest 10 shareholders include Octagon Capital Advisors LP (18.4M shares), NEA Management Company, LLC (18.1M shares), VANGUARD GROUP INC (10M shares), Alyeska Investment Group, L.P. (8.81M shares), ARCH Venture Management, LLC (8.06M shares), FMR LLC (7.93M shares), 683 Capital Management, LLC (6.98M shares), Palo Alto Investors LP (6.28M shares), SILVERARC CAPITAL MANAGEMENT, LLC (6.17M shares), and Samsara BioCapital, LLC (6.13M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.